OrbusNeich Medical Group Holdings Limited logo

OrbusNeich Medical Group Holdings Limited (Q8T)

Market Closed
15 Jul, 20:00
XFRA XFRA
0. 35
-0
-0.5714%
299.66M Market Cap
- P/E Ratio
0.4% Div Yield
231 Volume
- Eps
0.35
Previous Close
Add Transaction
Day Range
0.35 0.35
Year Range
0.29 0.65
Want to track Q8T and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

Q8T closed today lower at €0.35, a decrease of -0.5714% from yesterday's close, completing a monthly decrease of -5.9459% or -€0.02. Over the past 12 months, Q8T stock lost -7.9365%.
Q8T is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

Q8T Chart

People also search for

5IK
Inkeverse Group Ltd.
0.12
-3.3333%
ATN
ADTRAN Inc
10.46
-4.4749%
AdvancedAdvT Ltd.
1.78
0%
AN5
Alpha Systems Inc.
17.6
-2.2222%
SUT
Productive Technologies Co. Ltd.
0.03
-1.6129%

OrbusNeich Medical Group Holdings Limited (Q8T) FAQ

What is the stock price today?

The current price is €0.35.

On which exchange is it traded?

OrbusNeich Medical Group Holdings Limited is listed on XFRA.

What is its stock symbol?

The ticker symbol is Q8T.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.4%.

What is its market cap?

As of today, the market cap is 299.66M.

Has OrbusNeich Medical Group Holdings Limited ever had a stock split?

No, there has never been a stock split.

OrbusNeich Medical Group Holdings Limited Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Mr. David Chien CEO
XFRA Exchange
KYG6773B1005 ISIN
DE Country
1,477 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

OrbusNeich Medical Group Holdings Limited operates as an investment holding company with a primary focus on designing, developing, manufacturing, trading in, selling, and marketing medical devices and instruments aimed at treating coronary and peripheral vascular diseases. The company's operational footprint spans various regions including Japan, Europe, the Middle East, Africa, the Asia Pacific, the People’s Republic of China, and the United States. Founded in 2001 and headquartered in Shatin, Hong Kong, OrbusNeich Medical Group Holdings Limited operates under the umbrella of Harmony Tree Limited as its subsidiary. With its innovative product offerings and a wide-reaching geographic presence, the company plays a pivotal role in advancing the field of vascular intervention and treatment globally.

Products and Services

OrbusNeich Medical Group Holdings Limited offers an extensive portfolio of medical devices specifically designed to cater to the needs of percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. The array of products includes:

  • Semi-compliant Balloons: These are utilized for pre-dilatation and lesion preparation in vascular intervention procedures. Semi-compliant balloons are designed to open narrowed vessels before a stent is placed.
  • Scoring Balloons: Used for precise lesion preparation, scoring balloons incorporate cutting elements to score plaque, facilitating more effective dilation in resistant lesions.
  • Coronary Stents: These are mesh-like tubes of thin wire which are implanted into narrowed coronary arteries to help keep them open after angioplasty, thus improving blood flow to the heart muscle.
  • Non-compliant Balloons: Used for post-dilatation, these balloons are deployed to fully expand a stent after it has been placed in a coronary artery. Due to their non-compliant nature, they can achieve higher pressures without changing shape.
  • Specialty Catheters: OrbusNeich provides a variety of catheters designed for specific uses in PCI and PTA procedures, catering to the diverse needs of vascular interventions.

Through its comprehensive product lineup, OrbusNeich Medical Group Holdings Limited supports healthcare professionals in improving patient outcomes in coronary and peripheral vascular disease treatments.

Contact Information

Address: Building 20E, Sha Tin, Hong Kong
Phone: 852 2802 2288